Victory Capital Management
UTMD icon

Victory Capital Management’s Utah Medical Products UTMD Stock Holding History

Victory Capital Management’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,673
Closed -$152K – 2555
2025
Q2 		$152K Sell
2,673
-11,735
-81% -$638K ﹤0.01% 2283
2025
Q1 		$807K Hold
14,408
– – ﹤0.01% 1894
2024
Q4 		$886K Hold
14,408
– – ﹤0.01% 1858
2024
Q3 		$964K Buy
14,408
+11,735
+439% +$797K ﹤0.01% 1791
2024
Q2 		$179K Buy
2,673
+1,482
+124% +$101K ﹤0.01% 2224
2024
Q1 		$84.7K Buy
1,191
+265
+29% +$19.9K ﹤0.01% 2321
2023
Q4 		$78K Sell
926
-1,008
-52% -$83.6K ﹤0.01% 2382
2023
Q3 		$166K Hold
1,934
– – ﹤0.01% 2230
2023
Q2 		$180K Buy
1,934
+1,006
+108% +$94.8K ﹤0.01% 2221
2023
Q1 		$87.9K Hold
928
– – ﹤0.01% 2375
2022
Q4 		$93.3K Sell
928
-95
-9% -$8.67K ﹤0.01% 2370
2022
Q3 		$87K Sell
1,023
-13
-1% -$1.15K ﹤0.01% 2500
2022
Q2 		$89K Sell
1,036
-43
-4% -$3.67K ﹤0.01% 2475
2022
Q1 		$97K Buy
1,079
+49
+5% +$4.51K ﹤0.01% 2519
2021
Q4 		$103K Sell
1,030
-20
-2% -$2.04K ﹤0.01% 2572
2021
Q3 		$97K Sell
1,050
-130
-11% -$11.5K ﹤0.01% 2622
2021
Q2 		$100K Hold
1,180
– – ﹤0.01% 2601
2021
Q1 		$102K Buy
+1,180
New +$104K ﹤0.01% 2603
2020
Q2 		– Sell
-3,392
Closed -$320K – 3263
2020
Q1 		$320K Buy
3,392
+1,708
+101% +$159K ﹤0.01% 2226
2019
Q4 		$182K Buy
1,684
+323
+24% +$32.7K ﹤0.01% 2335
2019
Q3 		$130K Buy
+1,361
New +$126K ﹤0.01% 2358

Other funds holding UTMD

BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $155M AUM 35.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Victory Capital Management's UTMD Position: Q3 2025 in Review

Victory Capital Management sold out of Utah Medical Products (UTMD) in Q3 2025, closing a stake of 2,673 shares — an estimated $152K sold.

Victory Capital Management first reported a position in UTMD in Q3 2019 and held it in 21 quarters. The position peaked at $964K in Q3 2024. 117 funds tracked by Wall St. Rank hold UTMD as of Q3 2025.

  • Victory Capital Management reported no remaining Utah Medical Products position as of Q3 2025 after selling out during the quarter.
  • Victory Capital Management sold 2,673 Utah Medical Products shares in Q3 2025, an estimated $152K.
  • Victory Capital Management first reported a position in Utah Medical Products in Q3 2019 and held it in 21 quarters.
  • Victory Capital Management's Utah Medical Products position peaked at $964K in Q3 2024.
  • 117 funds tracked by Wall St. Rank held Utah Medical Products as of Q3 2025.

Based on Victory Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.